SUSTAINABILITY

We are intensifying our efforts to halve our environmental impact by 2029 from our 2019 totals, on our way to achieving net zero emissions by 2045 and absolute zero operational emissions by 2050.

Accelerated Targets for 2029

Using a 2022 baseline, we are committed to achieving the following milestones across all our sites by 2029 on our path to zero emissions:

More Than Two Decades of Sustainability Leadership

Sustainability is deeply ingrained in our business. In 2006, we were among the first biotech companies to publish our greenhouse gas and water reduction goals. Since then, we have continued to push boundaries through many industry-leading sustainability initiatives:

• Launching the first double-decker electric commuter bus program in the U.S. and expanding sustainable commute options that support our workforce and underserved communities.
• Championing healthy and sustainable design and construction, with Northern California’s first all-electric lab, and LEED Platinum, LEED Gold, WELL, and Fitwel certified facilities across our sites.
• Driving circularity in our labs through rigorous sustainable science practices, specialized recycling for nitrile gloves and rigid plastics, and donating chemicals and equipment to local community college reuse programs.
• Partnering with our internal community of 2,000+ sustainability advocates, Green Genes, to create lasting change. Since its start in 2003, members have spearheaded vital initiatives across our sites, from introducing reusables in our cafeterias to collecting thousands of pounds of waste through community cleanup efforts.

References

For more information on our sustainability goals and progress, including Genentech’s California SB 261 Climate-Related Financial Risk Report, view the Roche Annual Report.
Available online at: https://assets.roche.com/f/176343/x/fa3c863601/ar25e.pdf